Myeloid sarcoma, not having achieved remission, is a rare extramedullary manifestation of acute myeloid leukemia (AML) characterized by the proliferation of myeloid cells in tissues outside the bone marrow. This condition is clinically significant as it indicates a poor prognosis and requires immediate medical intervention. The ICD-10 Code C92.30 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this serious condition.
ICD-10 Code C92.30 represents Myeloid sarcoma, not having achieved remission, which occurs when myeloid cells infiltrate tissues, indicating an advanced stage of disease. This code should be used in clinical documentation and billing when a patient presents with myeloid sarcoma that has not responded to treatment, highlighting the need for ongoing management and intervention.
Myeloid sarcoma, not having achieved remission, is caused by the uncontrolled proliferation of myeloid precursor cells, often associated with acute myeloid leukemia. The condition can progress rapidly, leading to significant morbidity and necessitating urgent medical attention.
ICD-10 Code C92.30 is utilized in SOAP notes to document the presence of myeloid sarcoma that has not achieved remission. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C92.30 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of myeloid sarcoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Myeloid sarcoma, not having achieved remission, requires urgent treatment to manage the disease effectively. Hospitalization is often necessary for intensive therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.30 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C92.30 for Myeloid sarcoma, not having achieved remission
What are the common symptoms of Myeloid sarcoma?
Common symptoms include localized swelling, pain in affected areas, fever, and weight loss. Patients may also experience fatigue and night sweats due to the disease's systemic effects.
How is Myeloid sarcoma diagnosed?
Diagnosis typically involves imaging studies to identify extramedullary masses, along with laboratory tests to assess blood cell counts and confirm the presence of myeloid cells.
What treatments are available for Myeloid sarcoma?
Treatment options include chemotherapy, supportive care for symptom management, and close monitoring for complications. Hospitalization may be required for intensive therapy.
How does ICD-10 Code C92.30 affect billing?
ICD-10 Code C92.30 is essential for accurate billing as it specifies the diagnosis of Myeloid sarcoma, not having achieved remission, ensuring that healthcare providers are reimbursed for the necessary treatments and interventions.
Clinical Notes
SOAP notes
DAP notes
AI medical notes